Value of serum soluble syndecan- 1 as a biomarker of disease activity in ulcerative colitis patients
Abstract Background Inflammatory bowel disease (IBD) is a chronic and incurable disease that includes Crohn’s disease (CD) and ulcerative colitis (UC); UC is characterized by repeated episodes of relapse and remission despite treatment; Soluble syndecan-1(Sdc1) is a marker of activity for UC. This s...
Saved in:
| Main Authors: | Fatma M. Abdelsalam, Walid Abdellatif Abdelhalim, Ahmed M. Saleh, Tamer E. Eleraky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | Egyptian Liver Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43066-025-00414-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shed Syndecan-4 and Its Possible Roles in Osteoarthritis
by: Kangping He, et al.
Published: (2025-04-01) -
Severe obstructive colitis treated with repeated colonoscopic decompression
by: Junya Arai, et al.
Published: (2024-04-01) -
Wooden breast myopathy is characterized by satellite cell dysfunction and syndecan-4 shedding
by: Lucie Pejšková, et al.
Published: (2024-12-01) -
A comparative study of syndecan-1 expression in different odontogenic tumors
by: Shahroo Etemad-Moghadam, et al.
Published: (2017-01-01) -
Serum syndecan-1 is related to severity and prognosis of COVID-19 patients: a perspective cohort study
by: Mengmeng Ma, et al.
Published: (2025-07-01)